News & Analysis as of

Regulatory Requirements Antitrust Provisions

K&L Gates LLP

Private Equity in Australia: Upcoming Mandatory Merger Laws and Foreign Investment Changes

K&L Gates LLP on

WHAT’S ON THE AUSTRALIAN REGULATORY HORIZON? In this publication, we provide an overview of certain upcoming changes for private equity funds and their investors (both Australian and foreign) investing in Australia....more

A&O Shearman

UK government emphasises CMA’s independence while steering it to support UK growth and investment

A&O Shearman on

The UK government has issued the final version of its “strategic steer” to the Competition and Markets Authority (CMA), directing the authority to act in a way that prioritises growth and encourages investment in the UK. ...more

Carlton Fields

Executive Order Seeks to Eliminate Discrepancies in Drug Pricing Between United States and Other Countries

Carlton Fields on

President Trump’s highly publicized executive order 14297, titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” targets the discrepancy in drug pricing in the United States compared with...more

EDRM - Electronic Discovery Reference Model

April 2025 HSR Rebound: Regulatory Shifts, Tariff Tensions, and M&A Impacts

Background Note: The Hart-Scott-Rodino (HSR) Act established the Premerger Notification Program, requiring certain mergers and acquisitions to be reported to the Federal Trade Commission (FTC) and the Department of Justice...more

Morgan Lewis

New Tariffs, Old Risks: Antitrust Considerations

Morgan Lewis on

With regulatory scrutiny by governments on the rise, this LawFlash summarizes key antitrust issues for companies in all industries affected by tariffs. History shows that cartels tend to form in times of rapid economic...more

Alston & Bird

EC’s First In-Depth FSR Merger Decision – Initial Takeaways for Dealmakers

Alston & Bird on

Our Antitrust Team examines the European Commission’s first conditional merger clearance under the Foreign Subsidies Regulation (FSR) and how it provides key insights into how foreign financial contributions impact...more

Blake, Cassels & Graydon LLP

Droit de la concurrence et investissements étrangers dans un contexte de mesures tarifaires et de tensions commerciales

Le contexte économique actuel pourrait bien induire des changements dans les normes et les tendances relatives aux examens réalisés en vertu de la Loi sur la concurrence et de la Loi sur Investissement Canada) (la « LIC »)....more

Baker Botts L.L.P.

Saudi Arabia Responds to Investors with Revised Merger Guidelines Addressing Practical Needs

Baker Botts L.L.P. on

The Saudi General Authority for Competition (GAC) continues to develop its antitrust and competition regulatory framework to bring it in line with international standards. These efforts are part of the Kingdom’s broader goal...more

Morgan Lewis

M&A Considerations Across the Technology Sector

Morgan Lewis on

Technology is quickly becoming one of the most active and dynamic sectors for mergers and acquisitions (M&A) in 2025. Despite a macro environment filled with uncertainty, technology deal activity reflects an appetite for...more

Skadden, Arps, Slate, Meagher & Flom LLP

President Trump’s First 100 Days: Impacts and Projections

The first 100 days of a new administration sets the tone for policy direction and regulatory priorities. The following key takeaways from the Trump administration’s first three months highlight significant trends, shifts and...more

Blake, Cassels & Graydon LLP

Navigating Compliance: Competition Law and Foreign Investment Reviews Amid Tariffs and Trade Tension

The current economic climate has the potential to reshape traditional norms and patterns for regulatory reviews under the Competition Act and the Investment Canada Act (ICA)....more

Paul Hastings LLP

Check-Up and Diagnosis: The Ongoing Scrutiny of Private Equity Healthcare Investments

Paul Hastings LLP on

In 2024 alone, over 676 private equity firms and related investors acquired healthcare companies or related assets. The growing influence of private equity in the healthcare industry has not gone unnoticed on either of the...more

Paul Hastings LLP

Private Company Report: Q1 2025

Paul Hastings LLP on

This edition of the Private Company Report highlights critical developments and regulatory changes affecting private companies, including recent presidential actions, SEC guidance on Regulation D and amendments to the...more

Jones Day

German Regulator Highlights Antitrust Risks Associated With The Use Of Industry Initiatives For Supply Chain Due Diligence

Jones Day on

The EU's Corporate Sustainability Due Diligence Directive (CS3D) stresses that industry initiatives (next to multi-stakeholder initiatives) can constitute helpful tools for allowing covered companies to fulfill their...more

McDermott Will & Emery

Navigating the Regulatory Landscape for Private Label Alcohol

Private labels are not a new concept – many consumers have purchased private label products for years, but their use is becoming more prevalent and ubiquitous in the market as demand for private labels continues to rise. ...more

Thomas Fox - Compliance Evangelist

Daily Compliance News: May 1, 2025, The 100 Days of Corruption Edition

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy morning coffee, and listen to the Daily Compliance News. All, from the...more

Bass, Berry & Sims PLC

Washington Enacts “Mini-HSR” Law, Expanding State-Level Premerger Filing Requirements

Bass, Berry & Sims PLC on

On April 4, Washington became the first state to adopt the Uniform Premerger Notification Act (Act) when Washington Governor Jay Inslee signed the bill into law. The new statute imposes state-level premerger filing...more

McCarter & English, LLP

Antitrust Implications for Companies Facing Tariffs

If all of the Trump administration’s proposed tariffs take effect, the impact of those tariffs on the US economy and the American people will likely be debated for years to come. Regardless of the outcome of that debate,...more

Hogan Lovells

Staying antitrust compliant: New BAFA guidance on sector initiatives in supply chain due diligence

Hogan Lovells on

Supply chain due diligence has firmly taken root in the global regulatory landscape, setting clear compliance expectations on how companies should identify, assess, and address human rights and environmental risks across...more

A&O Shearman

UK CMA review of the SME Banking Undertakings 2002

A&O Shearman on

The UK's Competition and Markets Authority (CMA) has confirmed its decision to review the remaining SME Banking Undertakings 2002 and has launched its consultation seeking views on whether the undertakings need to be updated....more

Latham & Watkins LLP

A New Era for Consumer Protection: The Digital Markets, Competition and Consumers Act

Latham & Watkins LLP on

An overhaul of the UK consumer law landscape is on the horizon, with the consumer law provisions of the Digital Markets, Competition and Consumers Act 2024 set to take effect on 6 April 2025....more

K&L Gates LLP

Australian Mandatory Merger Clearance: Regime Details Starting to Emerge – Government Publishes Draft Determination, ACCC...

K&L Gates LLP on

On 28 March 2025, the Australian Government (the Government) published its draft Determination providing the beginnings of detail about the acquisitions that are the subject of mandatory notification, some of the exceptions...more

Akin Gump Strauss Hauer & Feld LLP

Combating Unfair Practices in the Live Entertainment Market (Trump EO Tracker)

Requires the Attorney General and the Federal Trade Commission (FTC) to ensure that competition laws are appropriately enforced in the concert and entertainment industry when venues, ticketing agencies, or a combination are...more

DLA Piper

The Future of "Counterparty Bribery" Offenses Under China's Anti-Unfair Competition Law

DLA Piper on

Pending proposals to amend China's Anti-Unfair Competition Law (AUCL) may further blur the line between antitrust and anti-corruption offenses under China's enigmatic "counterparty bribery" rules. The AUCL, first enacted in...more

Rivkin Radler LLP

State Laws Target Healthcare Investments as Feds Deregulate

Rivkin Radler LLP on

Will the new administration’s federal deregulation be a boon for private equity investment in healthcare providers, or will the states be the “new sheriff in town”? In the short time he has been in office, President Trump...more

114 Results
 / 
View per page
Page: of 5

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide